First Round Capital is a founder-first early-stage venture firm that concentrates on the earliest company-building moments, primarily across the U.S. They back outlier founders with contrarian insight into large markets and pair capital with unusually hands-on support in recruiting, go-to-market, pricing, board building, and Series A preparation.
Evaluation weights
How much weight this firm places on each dimension. Totals 100%.
Revenue, growth, and unit economics
Size, timing, and competitive landscape
Founder experience and execution ability
Differentiation and technical quality
- Bias toward exceptional founders over polished early metrics
- Bias for true early-stage opportunities rather than late-seed financings
- Bias toward U.S.-based companies where the firm can add operating leverage
- Bias for contrarian, category-shaping ideas over consensus startup themes
Pitch difficulty
How hard it is to get a meeting and close funding from this firm.
- Funded / yr
- 46Deals closed in a typical year.
- Led / yr
- 14Rounds led in the last 12 months.
- Pitches / yr
- ~4316Decks reviewed in a typical year.
- Acceptance rate
- 1.1%Share of pitches that get funded.
Estimated — public data is not fully disclosed.
Why it's hard
- Team quality is the dominant filter and the bar is unusually high
- The firm focuses narrowly on early-stage rounds and rejects late-seed mismatches
- Primarily invests in U.S.-based companies
- Looks for contrarian founder insight into very large markets, not generic startup pitches
First Round is willing to invest before revenue and without hard traction requirements, which makes them more accessible than firms demanding mature metrics. However, they are highly selective on founder quality, true early-stage fit, and U.S. geography, and they avoid companies that have already raised too much capital for their entry point.
Green flags
What drives a yes for this firm.
- An exceptional founding team with outlier abilities and strong founder-market fit
- A contrarian insight that teaches the firm something new about the future
- A market large enough to be a prize worth winning
- Clear founder vision on why this is the right product and timing
- Evidence the founders will benefit from and engage with First Round's high-touch support
Red flags
What kills deals and gets a fast no.
- A company that has already raised several million dollars and no longer fits early-stage entry
- Non-U.S. domicile without a strong U.S.-based founder setup
- A generic pitch with no contrarian insight or exceptional founder story
- Small or unconvincing market opportunity
- Founders looking for passive capital and resisting deep investor involvement
How to win
Patterns that lead to successful pitches.
- Lead with the founder's unique insight and why this team sees the future differently
- Position the company as a true early-stage opportunity where First Round's hands-on support will matter
- Show a path to a very large market while starting from a sharp initial wedge
- If traction exists, present high-quality customer pull rather than inflated vanity metrics
- Demonstrate openness to close partnership on hiring, GTM, pricing, and Series A preparation
Fund strategy & identity
Who they are and how they operate.
- Invests primarily at Pre-Seed and Seed, with selective Series A participation
- Writes initial checks typically in the $1M-$7M range
- Can lead or follow, but becomes deeply involved when leading
- Focuses on U.S.-based companies where its platform and network are strongest
- Uses intensive operating support to accelerate product-market fit and next-round readiness
Firm identity
Investment focus
Industries, themes, and typical ARR expectations.
Industries
Investment themes
Typical check by stage
Typical ARR by stage
Investment thesis
Core beliefs and strategy behind their investing approach.
First Round concentrates exclusively on the earliest stages—angel, pre‑seed and seed—across the United States, with a few occasional exceptions for U.S.-based founders operating abroad. Their sector focus is not prescriptive, but investments cluster around enterprise, AI, hardware, healthcare, fintech and consumer, driven by founder‑led, contrarian insights into large, prize‑worthy markets. The firm’s core belief is that the earliest moments of a startup determine its trajectory, so they provide high‑touch operational support—recruiting, GTM, pricing, board building and Series A preparation—to accelerate product‑market fit. They avoid late‑seed rounds where several million dollars have already been raised and generally do not invest in non‑U.S. domiciled companies, preferring to leverage their deep network and resources within the U.S. ecosystem. Value creation is delivered through hands‑on partnership rather than passive capital provision.
Decision patterns
How they evaluate and make investment decisions.
First Round’s primary decision factor is the founding team. They look for founders with outlier abilities, deep curiosity and a contrarian insight into how the world works. Product and market potential are secondary: they assess whether the market is large enough to be a prize worth winning and whether the team’s vision aligns with that opportunity. Traction is not a hard requirement; many investments were made when the company had only an idea, though early customer interest is appreciated when a product exists. Deal‑breakers include companies that have already raised several million dollars or are outside the U.S., indicating a mis‑fit in stage or geography. The firm does not require a lead position, but when it leads it becomes highly involved with board seats and intensive operating support.
Risk appetite
First Round exhibits an aggressive, high‑conviction risk appetite. They invest at the pre‑revenue, idea stage and do not require customers or revenue, reflecting comfort with early‑stage uncertainty. The firm is flexible on lead versus follow positions, stating they do not care about lead terms but will take a board seat and deep involvement when they lead. Partner commentary emphasizes that they get paid to take risk, not avoid it, highlighting a willingness to underwrite contrarian teams early while remaining flexible in co‑investments.
Notable investments
Key portfolio companies and why they fit the thesis.
- UberLeadLed Uber's 2010 seed round (UberCab); first institutional backer of a contrarian on-demand model before the on-demand economy exploded.
- NotionLeadLed Notion's $2M seed in 2013; product-first team rethinking documents as software.
- LookerLeadSeed-stage bet on modern data-analytics infrastructure; strong founder-market fit and product insight pre-PMF.
- RobloxExtremely early bet on a user-generated gaming platform before mainstream breakout.
- SquareEarly belief in enabling simple, ubiquitous payments via mobile; strong founder pedigree and large market.
- Warby ParkerEarly DTC contrarian thesis in eyewear; First Round participated in the 2011 round alongside Lerer Hippeau.
- Flatiron HealthEarly health-tech thesis leveraging data/insight; aligns with First Round's appetite for AI-enabled healthcare.
- UpstartTeam-centric bet on algorithmic underwriting and a contrarian approach to consumer credit eligibility.
- Clover HealthEarly entrance into tech-enabled insurance with healthcare data as a core advantage.
- KandjiOpenness to cold outreach and early belief in enterprise device management with passionate early customers.
Co-invested with
Other firms in this catalog who've backed the same companies.
Partners
Full firm roster — key partners, partners, and the wider team.
Key partners
Josh Kopelman
Partner
First Round Capital
Partner and co-founder of First Round, with a background as a repeat founder and early-stage investor.
Brett Berson
Partner
First Round Capital
Partner at First Round who works across investing and operating, and helped build The Review, Angel Track, and the In Depth podcast.
Bill Trenchard
Partner
First Round Capital
Partner at First Round and repeat founder who looks for pre-product-market-fit founders solving complex problems.
Todd Jackson
Partner
First Round Capital
Todd Jackson is a Partner at First Round Capital focused on helping early-stage founders navigate product-market fit.
Liz Wessel
Partner
First Round Capital
Liz Wessel is a Partner at First Round Capital and former founder/CEO of WayUp.
Hayley Barna
Partner
First Round Capital
Hayley Barna is a Partner at First Round Capital and former co-founder of Birchbox. She focuses on founders tackling overlooked or seemingly unsolvable problems across areas such as healthcare, climate, supply chain, and commerce.
Amy Fu
Vice President
First Round Capital
Amy Fu is a Vice President at First Round Capital. Her official profile places her at a firm focused exclusively on the earliest stages of company building.
Partners
Joshua Fink
Founder and Managing Partner, Luma Group
First Round Capital
Founder of Luma Group investing in biotech, medical devices and healthcare technology.
Hayley Bay Barna
Partner
First Round Capital
First Round partner and Birchbox co-founder investing in healthcare, climate, supply chain and commerce.
Roy Rosin
Board Partner
First Round Capital
First Round Board Partner focused on healthcare, product strategy and early company-building.
Team
Nick Rubin
Investor
First Round Capital
Generalist First Round investor and former YC founder of Sendo.
Nyle Sykes
Investor
First Round Capital
Generalist First Round investor with prior early-stage technology investing experience at NEA.
Emery Rosansky
VP, Founder Success & GTM
First Round Capital
First Round GTM leader helping early founders land customers and build repeatable sales motions.
Public voice
Notable statements and public positions.
- “We don’t think VCs predict the future — founders do. And we look to founders to teach us what’s next.” (First Round, Who We Back)
- “When we lead your first round, we’re all in.” (First Round, How We Work)
- “I try to provide two things: my unvarnished opinion and my unwavering support… great companies are built by great founders, not great investors.” (Josh Kopelman, Team bio)
Similar firms
Firms with overlapping stage and industry focus.
Initialized Capital
3.1%
Kleiner Perkins
1.0%
Andreessen Horowitz
0.5%